Jeffrey Lipman's Publications

About Jeffrey Lipman's Publications

Honorary Professorial Fellow
  • Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

    Trials Date published:
  • From the intensive care bed: we need to hear and listen

    Intensive Care Medicine Date published:
  • Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients

    Journal of Antimicrobial Chemotherapy Date published:
  • A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections

    BMC Infectious Diseases Date published:
  • Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration

    International Journal of Antimicrobial Agents Date published:
  • Comparison of the Accuracy and Precision of Pharmacokinetic Equations To Predict Free Meropenem Concentrations in Critically Ill Patients

    Antimicrobial Agents and Chemotherapy Date published:
  • The Durban World Congress Ethics Round Table Conference Report: I. Differences between withholding and withdrawing life-sustaining treatments

    Journal of Critical Care Date published:
  • The Durban World Congress Ethics Round Table Conference Report: II. Withholding or withdrawing of treatment in elderly patients admitted to the intensive care unit

    Journal of Critical Care Date published:
  • The Durban World Congress Ethics Round Table Conference Report: III. Withdrawing Mechanical ventilation-the approach should be individualized

    Journal of Critical Care Date published:
  • The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study

    Critical Care Date published:
  • Vancomycin-Associated Nephrotoxicity in the Critically Ill

    Critical Care Medicine Date published:
  • Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds

    Critical Care Date published:
  • How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

    BMC Infectious Diseases Date published:
  • Interethnic Differences in Pharmacokinetics of Antibacterials

    Clinical Pharmacokinetics Date published:
  • The effect of pathophysiology on pharmacokinetics in the critically ill patient - Concepts appraised by the example of antimicrobial agents

    Advanced Drug Delivery Reviews Date published:
  • Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections

    International Journal of Antimicrobial Agents Date published: